文献速递心力衰竭与心肌病

心肌钙调节剂、肌调节剂与线粒体调节剂:JACC每周综述

Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

传统正性肌力药通过调节心肌钙信号发挥作用,但长期预后不佳。本文提出基于心肌机制的三个新分类:钙调节剂(改变细胞内钙浓度)、肌调节剂(影响分子马达和支架)、线粒体调节剂(影响能量代谢),以更精准描述和评估改善心肌性能的药物。

要点

  • 传统正性肌力药长期预后不佳,新药开发旨在摆脱钙介导机制。
  • 新框架按机制分为钙调节剂、肌调节剂和线粒体调节剂。
  • 该分类有助于区分药物机制和临床结局,促进研发沟通。

核心结论

  • 「正性肌力」不足以描述改善心肌性能药物的多样性,需采用钙调节剂、肌调节剂和线粒体调节剂的新分类框架。

研究设计与样本

  • 综述文章,未报告系统检索范围或样本量。

主要发现

  • 传统正性肌力药通过调节心肌钙信号发挥作用,与不良长期结局相关。
  • 新开发分子旨在靶向不同机制以改善心脏性能,避免钙介导的长期不良效应。
  • 新分类基于三种心肌机制:钙调节剂改变细胞内钙浓度,肌调节剂影响分子马达和支架,线粒体调节剂影响能量代谢。

临床怎么用

  • 临床医生可依据新框架理解药物机制,评估当前和新兴疗法。
  • 新化学实体可纳入该框架,根据机制和临床结局区分。

局限性

  • 综述文章,未报告系统检索策略或纳入研究的偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The term "inotrope" is familiar and intimately connected with pharmaceuticals clinically used for treatment of low cardiac output with cardiogenic shock. Traditional inotropic agents exert their effect by modulating calcium signaling in the myocardium. Their use is associated with poor long-term outcomes. Newer molecules in development intend to break from calcium mediation and the associated detrimental long-term effects by targeting distinct mechanisms of action to improve cardiac performance. Thus, "inotropy" does not sufficiently describe the range of potential novel pharmaceutical products. To enhance communication around and evaluation of current, emerging, and potential therapies, this review proposes a novel nuanced and holistic framework to categorize pharmacological agents that improve myocardial performance based on 3 myocardial mechanisms: calcitropes, which alter intracellular calcium concentrations; myotropes, which affect the molecular motor and scaffolding; and mitotropes, which influence energetics. Novel chemical entities can easily be incorporated into this structure, distinguishing themselves based on their mechanisms and clinical outcomes.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Psotka MA, Gottlieb SS, Francis GS, et al. Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week. J Am Coll Cardiol. 2019. PMID: 31072579. doi:10.1016/j.jacc.2019.02.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。